17 Results for "

EGFR-TK

" in MedChemExpress (MCE) Product Catalog:
Products (17)

17 Results for "EGFR-TK" in MCE Product Catalog:

Cat. No.: HY-161927
CAS No.: 3053485-72-3
Target:  

EGFR Apoptosis

Research Areas:  

Cancer

EGFR-TK-IN-4 (compound 10k) is a potent and selective EGFR-TK inhibitor. EGFR-TK-IN-4 can induce apoptosis . EGFR-TK-IN-4 has antitumor activity .
loading...
    loading...
Cat. No.: HY-158018
Target:  

EGFR

Research Areas:  

Cancer

EGFR-TK-IN-2 (compound 10b) is EGFR-TK inhibitor with the IC50 of 0.16 μM. EGFR-TK-IN-2 inhibits cell growth .
loading...
    loading...
Cat. No.: HY-144445
CAS No.: 24909-18-0
Target:  

EGFR

Research Areas:  

Cancer

NSC114126 is a potent and orally active inhibitor of EGFR tyrosine kinase (EGFR-TK). NSC114126 has strong antiproliferative activities. NSC114126 has the potential for the research of cancer diseases .
loading...
    loading...
Cat. No.: HY-179150
Target:  

EGFR Tyrosinase

Research Areas:  

Cancer

EGFR-TK-IN-6 (compound 10B) is an EGFR-TK inhibitor (IC50 = 0.65 μM). EGFR-TK-IN-6 has anti proliferative activity against MCF-7 cells (IC50 = 37.7 μM). EGFR-TK-IN-6 has low toxicity to normal cells. EGFR-TK-IN-6 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-172156
Target:  

EGFR

Research Areas:  

Cancer

EGFR-TK-IN-5 (Compound NCE 2) is a thiazolyl-pyrazoline derivative. EGFR-TK-IN-5 exhibits strong inhibitory activity and stability against EGFR. EGFR-TK-IN-5 can be used in the study of cancer .
loading...
    loading...
Cat. No.: HY-163860
Target:  

EGFR

Research Areas:  

Cancer

EGFR-TK-IN-3 (3) is an EGFR TK inhibitor, with an IC50 of 2.33 μM against Erlotinib (HY-50896)-resistant A549 cells .
loading...
    loading...
Cat. No.: HY-157526
Target:  

EGFR Apoptosis

Research Areas:  

Cancer

EGFR-TK-IN-1 (compound 7o) is a potent mutant EGFR inhibitor with IC50 of 8.5 nM an 9.3 nM against EGFR L858R/T790M and EGFR Del19.EGFR-TK-IN-1 showes strong antiproliferative effects against EGFR mutant-driven non-small cell lung cancer (NSCLC) cells and induces cell apoptosis .
loading...
    loading...
Cat. No.: HY-146422
CAS No.: 2409793-36-6
Target:  

PROTACs EGFR Apoptosis

Research Areas:  

Cancer

PROTAC EGFR degrader 5 (Compound 10), a PROTAC EGFR degrader, potently degrades EGFR Del19 in HCC827 cells with the DC50 of 34.8 nM. PROTAC EGFR degrader 5 significantly induces the apoptosis of HCC827 cells and arrest the cells in G1 phase .
loading...
    loading...
Cat. No.: HY-144441
CAS No.: 1678-14-4
Target:  

EGFR

Research Areas:  

Cancer

NSC81111 is a potent and orally active EGFR-TK inhibitor with an IC50 of 0.15 nM. NSC81111 has anticaner effects .
loading...
    loading...
Cat. No.: HY-147303
CAS No.: 1351941-69-9
Target:  

Trk Receptor EGFR

Research Areas:  

Cancer

Sacibertinib is a tyrosine kinase (Trk) inhibitor with EC50 value of 110 nM and 244 nM for EGFR-TK phosphorylation and HER2, respectively. Antineoplastic activity .
loading...
    loading...
Cat. No.: HY-144444
CAS No.: 1033006-96-0
Target:  

EGFR

Research Areas:  

Cancer

NSC381467 is a potent and orally active inhibitor of EGFR tyrosine kinase (EGFR-TK). NSC381467 has strong antiproliferative activities. NSC381467 has the potential for the research of cancer diseases .
loading...
    loading...
Cat. No.: HY-149846
CAS No.: 2151881-74-0
Target:  

EGFR

Research Areas:  

Cancer

SIQ17 is an EGFR inhibitor that inhibits its activity by occupying the ATP-binding site, with IC50 of 0.62 nM. SIQ17 shows more effective EGFR-TK inhibitory activity compared to the known inhibitor Erlotinib (HY-50896) (IC50 of ∼20 nM). SIQ17 can be used for cancer research
loading...
    loading...
Cat. No.: HY-158016
Target:  

EGFR Apoptosis

Research Areas:  

Cancer

Antiproliferative agent-49 (Compound 5a) is a EGFR-TK inhibitor with an IC50 of 0.09 μM. Antiproliferative agent-49 is a anti-proliferative agent. Antiproliferative agent-49 displays good activities against HER3 and HER4 with IC50 values 0.18 and 0.37 µM. Antiproliferative agent-49 induces mitochondrial apoptotic pathway and increased accumulation of ROS .
loading...
    loading...
Cat. No.: HY-146138
CAS No.: 2492382-37-1
EGFR-IN-57 (Compound 25a) is a potent, orally active EGFR-TK inhibitor with an IC50 of 0.054 µM. EGFR-IN-57 also inhibits VEGFR-2, CK2α, topoisomerase IIβ and tubulin polymerization with IC50 values of 0.087, 0.171, 0.13 and 3.61 µM, respectively. EGFR-IN-57 induces cell cycle arrest at G2/M and pre-G1 phases. EGFR-IN-57 induces cancer cell apoptosis .
loading...
    loading...
Cat. No.: HY-173314
Target:  

EGFR Apoptosis

Research Areas:  

Cancer

EGFR-IN-155 (compound 13a) is an EGFR inhibitor with IC50 values of 0.14 nM and 0.18 nM against EGFR TK and EGFR L858R, respectively. EGFR-IN-155 inhibits tumor growth, causes a cell cycle arrest at S phase, and and induces cell apoptosis .
loading...
    loading...
Cat. No.: HY-172897
EGFR/DHFR-IN-2 (9b) is a dual h-DHFR/EGFR TK inhibitor, with IC50 values of 0.192 μM and 0.109 μM for h-DHFR and EGFR, respectively. EGFR/DHFR-IN-2 (9b) halts the cell cycle at the G1/S phase and induces apoptosis. EGFR/DHFR-IN-2 (9b) is a potential inhibitor of CYP2C9 and CYP3A4. EGFR/DHFR-IN-2 (9b) can be used in the cancer research .
loading...
    loading...
Cat. No.: HY-180823
Research Areas:  

Cancer

Topoisomerase II/EGFR-IN-2 (Compound 3) is an inhibitor of Topoisomerase IIα (IC50 = 0.122 μM) and EGFR-TK WT (IC50 = 16.8 μM). Topoisomerase II/EGFR-IN-2 inhibits the proliferation of HeLa and HepG2 cells, inducing cell cycle arrest and apoptosis. Topoisomerase II/EGFR-IN-2 upregulates caspase-3 and Bax, and downregulates Bcl-2. Topoisomerase II/EGFR-IN-2 can be used to study liver cancer and cervical cancer .
loading...
    loading...
  • 1